Press Coverage

Recently, the District Court in Düsseldorf lifted several ex-parte preliminary injunctions granted for Merck Sharpe & Dohme Corp. (MSD) against...

Numerous generics manufacturers are now allowed to sell their imitator preparations of the cholesterol-lowering drug Inegy in Germany. The Düsseldorf...

The so-called second medical use of medicaments is currently one of the most important topics in European patent law. The Düsseldorf Regional Court...

Out of concern for the quality of patent granting by the European Patent Office (EPO), four law firms have addressed an open letter to the current...

The supplementary protection certificate of the US pharma company Gilead, which covers the active agent combination of the HIV medicament TRUVADA®,...

Is it required that an active or an exact active combination is explicitly mentioned in the underlying patent, in order to allow a supplementary...

The law is actually very clear about the circumstances under which applicants may still change the claimed scope of protection of an application in...

Seven manufacturers of pharmaceuticals may for the time being continue marketing their generic products based on the HIV drug Truvada in Germany. The...

Mundipharma has achieved a first success in defending the patent on its Targin analgesic. The Regional Court of Munich granted interim injunctions...